Obamacare: Details Between White House and Pharmaceutical Companies Emerge
- Details
- Created on Tuesday, 05 June 2012 07:17
- Written by Chuck Justice
Getting the pharmaceutical industry to comply with the massive new rules and regulations in Obamacare was no easy task. While the bill was crafted behind closed doors by very liberal special interest groups, top Democrats and Obama's advisers, pharmaceutical lobbyists also played an extensive role, as revealed in new emails. The pattern has been established: if the political price is right, the White House is for sale, as long as it promotes their radical agenda.